Keyword "STATINS" found in the following publications:

• CONCOMITANT USE OF STATINS AND S-(2-BORON-ETHYL)-L-CYSTEINE ARGINASE INHIBITOR TO CORRECT ENDOTOXIN-INDUCED ENDOTHELIAL DYSFUNCTION

  The concomitant use of non-selective S-(2-boron-ethyl)-L-cysteine (BEC) arginase inhibitor with simvastatin, atorvastatin, rosuvastatin and nanoparticulated rosuvastatin on the background of ...

  Abstract | Full text (PDF)

• LIPID DISTRESS-SYNDROME AND PROSPECTS OF ITS CORRECTION BY STATINES

  Endothelial dysfunction in peritonitis: The formed concept of lipid distress syndrome (LDS) allows us to develop a working hypothesis ...

  Abstract | Full text (PDF)

• APPLICATION OF THE PRINCIPLE OF SIMILARITY IN THE DEVELOPMENT OF MEDICINAL COMPOSITIONS WITH THE USE OF HERBAL RAW MATERIAL

  The article discusses the possibility of developing a combination of drugs for the treatment of atherosclerosis in elderly patients. Atherosclerosis ...

  Abstract | Full text (PDF)

• PHARMACOTHERAPEUTIC STRATEGIES FOR ENDOTHELIAL DYSFUNCTION CORRECTION WITH USE OF STATINES IN SYNDROME OF SYSTEMIC INFLAMMATORY RESPONSE

  Objectives: The ways of pharmacological correction of cardiovascular complications in the syndrome of the systemic inflammatory response (SIRS) are ...

  Abstract | Full text (PDF)

• PHARMACOLOGICAL EFFICIENCY OF STATINS AND L-NORVALIN AT AN ENDOTOXIN-INDUCED ENDOTHELIAL DYSFUNCTION

  In the animals with endotoxin-induced endothelial dysfunction there were imbalance of contractile response of vessels wall observes when carrying out ...

  Abstract | Full text (PDF)

• ANALYSIS OF CHANGES IN PHARMACOTHERAPY OF STABLE ANGINA OVER THE FIVE-YEAR PERIOD AT SPECIALIZED OUT-PATIENT LEVEL OF MEDICAL CARE (PHARMACOEPIDEMIOLOGICAL STUDY)

  Introduction: Ischemic heart disease (IHD) remains the leading cause of death both in Europe and in Russia. The most ...

  Abstract | Full text (PDF)